Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...
IFI will be part of GIFT’s three-tier plan to develop a 360-degree ecosystem for fintech operations and education.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback